News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
15,073 Results
Type
Article (834)
Company Profile (6)
Press Release (14233)
Section
Business (4045)
Career Advice (17)
Deals (669)
Drug Delivery (2)
Drug Development (4092)
Employer Resources (4)
FDA (176)
Job Trends (232)
News (8258)
Policy (380)
Tag
Academia (92)
Adcomms (1)
Allergies (2)
Alliances (1132)
ALS (4)
Alzheimer's disease (57)
Antibody-drug conjugate (ADC) (8)
Approvals (175)
Artificial intelligence (3)
Autoimmune disease (1)
Bankruptcy (5)
Best Places to Work (214)
Biotechnology (6)
Bladder cancer (8)
Brain cancer (3)
Breast cancer (12)
Cancer (173)
Cardiovascular disease (1)
Career advice (15)
CAR-T (4)
Cell therapy (22)
Clinical research (3141)
Collaboration (28)
COVID-19 (86)
C-suite (13)
Data (110)
Diabetes (3)
Diagnostics (33)
Diversity, equity & inclusion (2)
Drug discovery (2)
Drug pricing (2)
Earnings (1453)
Employer resources (4)
Events (3238)
Executive appointments (24)
FDA (203)
Frontotemporal dementia (1)
Funding (30)
Gene editing (2)
Gene therapy (4)
GLP-1 (13)
Government (33)
Grass and pollen (1)
Healthcare (591)
Immunology and inflammation (12)
Indications (2)
Infectious disease (90)
Inflammatory bowel disease (9)
Influenza (2)
Intellectual property (7)
Interviews (3)
IPO (425)
IRA (2)
Job creations (19)
Job search strategy (13)
Layoffs (8)
Legal (42)
Liver cancer (7)
Lung cancer (24)
Lymphoma (14)
Management (1)
Manufacturing (3)
MASH (1)
Medical device (129)
Medtech (129)
Mergers & acquisitions (264)
Metabolic disorders (9)
Multiple sclerosis (11)
Neurodegenerative disease (6)
Neuroscience (80)
NextGen: Class of 2025 (164)
Non-profit (39)
Obesity (3)
Opinion (4)
Ovarian cancer (3)
Pain (1)
Pancreatic cancer (9)
Parkinson's disease (7)
Patents (13)
Patient recruitment (2)
Peanut (1)
People (1328)
Phase I (1496)
Phase II (1627)
Phase III (572)
Pipeline (60)
Policy (2)
Postmarket research (18)
Preclinical (666)
Prostate cancer (8)
Rare diseases (9)
Real estate (37)
Recruiting (1)
Regulatory (353)
Research institute (87)
Resumes & cover letters (3)
Series A (4)
Series B (3)
Sickle cell disease (2)
Startups (98)
Supply chain (1)
Vaccines (24)
Weight loss (2)
Date
Today (3)
Last 7 days (34)
Last 30 days (84)
Last 365 days (1157)
2025 (346)
2024 (1265)
2023 (1667)
2022 (1965)
2021 (1957)
2020 (1578)
2019 (952)
2018 (722)
2017 (766)
2016 (676)
2015 (753)
2014 (461)
2013 (278)
2012 (211)
2011 (227)
2010 (183)
Location
Africa (8)
Alabama (2)
Arizona (1)
Asia (750)
Australia (355)
California (255)
Canada (94)
China (6)
Colorado (17)
Connecticut (5)
Delaware (1)
Europe (2623)
Florida (51)
Georgia (1)
Idaho (3)
Illinois (18)
Japan (1)
Kansas (1)
Maine (1)
Maryland (14)
Massachusetts (123)
Michigan (1)
Minnesota (1)
Missouri (2)
Montana (8)
Nevada (1)
New Jersey (43)
New York (91)
North Carolina (14)
Northern California (74)
Ohio (4)
Oregon (1)
Pennsylvania (40)
Rhode Island (3)
South America (7)
Southern California (138)
Texas (17)
United States (755)
Utah (3)
Virginia (9)
Washington State (41)
15,073 Results for "innate immunotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innate Pharma Announces €15M Investment by Sanofi
April 24, 2025
·
6 min read
Press Releases
OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025
April 23, 2025
·
5 min read
Press Releases
Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum
April 3, 2025
·
4 min read
Press Releases
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 22, 2025
April 16, 2025
·
5 min read
Press Releases
Innate Pharma Reports Full Year 2024 Financial Results and Business Update
March 27, 2025
·
19 min read
Press Releases
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
April 9, 2025
·
4 min read
Press Releases
Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference
March 25, 2025
·
4 min read
Press Releases
Innate Pharma Announces Conference Call and Webcast for Full Year 2024 Financial Results
March 20, 2025
·
4 min read
Press Releases
Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
February 27, 2025
·
4 min read
Press Releases
Innate Pharma Proposes to Its Shareholders to Transform Its Corporate Governance Structure Into a Board of Directors and to Change Its Composition
April 16, 2025
·
9 min read
1 of 1,508
Next
